Home

Content about HPV

02.06.10
HPV vaccination programs may reduce genital diseases

High-coverage human papillomavirus (HPV) vaccinations among adolescents and young women may result in a rapid reduction of genital warts, cervical cell abnormalities, and diagnostic and therapeutic procedures, researchers report in a new study published online February 5 in the Journal of the National Cancer Institute. Some of these genital abnormalities are precursors of cervical, vulvar, and vaginal cancers.

12.04.09
HPV Vaccine: Continuous Protection Beyond Six Years

An article published Online First and in an upcoming edition of The Lancet reports that the 'Cervarix' human papilloma virus (HPV) vaccine from GlaxoSmithKline offers continued protection beyond six years from infection against the types of HPV most commonly associated with cervical cancer (HPV-16 and HPV-18)...

06.26.09
HPV Testing For Cervical Screening Investigated

New research, published in The Lancet Oncology, has found that combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase the detection of cervical cancer compared with LBC screening alone. The trial funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme aimed to determine whether testing for HPV in the cervix might increase the effectiveness of the cervical screening programme.

02.17.09
One in four California adolescent girls has had HPV vaccine

divLess than two years after the#160;HPV#160;vaccine was approved as a routine vaccination for girls aged 11#160;and older, one-quarter of California adolescent girls have started the series of shots that protect against human papillomavirus, which is strongly linked to cervical cancer./div div#160;/div divAdditionally, a majority of teen girls, parents and young women in California say they would like to have the vaccine, according to a new policy brief released today by the a...